Amedisys, Inc. (NASDAQ:AMED) Receives Consensus Rating of “Hold” from Analysts

Amedisys, Inc. (NASDAQ:AMED) has earned an average rating of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $100.75.

Separately, Stephens restated an “equal weight” rating and issued a $101.00 price target on shares of Amedisys in a research note on Wednesday.

Amedisys Price Performance

NASDAQ:AMED traded up $0.13 during trading hours on Wednesday, hitting $92.65. The company’s stock had a trading volume of 57,623 shares, compared to its average volume of 269,353. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company has a market capitalization of $3.03 billion, a P/E ratio of 36.76, a PEG ratio of 1.82 and a beta of 0.73. Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. The stock has a fifty day simple moving average of $89.66 and a 200-day simple moving average of $93.69.

Hedge Funds Weigh In On Amedisys

Several large investors have recently modified their holdings of the business. Creative Planning boosted its holdings in Amedisys by 7.4% during the second quarter. Creative Planning now owns 4,295 shares of the health services provider’s stock worth $394,000 after purchasing an additional 295 shares during the last quarter. CWM LLC lifted its holdings in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after acquiring an additional 277 shares during the period. Inspire Investing LLC boosted its position in Amedisys by 11.2% in the third quarter. Inspire Investing LLC now owns 4,250 shares of the health services provider’s stock worth $410,000 after purchasing an additional 428 shares during the last quarter. Exchange Traded Concepts LLC raised its stake in shares of Amedisys by 6.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,508 shares of the health services provider’s stock worth $725,000 after purchasing an additional 450 shares during the period. Finally, Signaturefd LLC boosted its holdings in shares of Amedisys by 20.9% in the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock worth $132,000 after buying an additional 236 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.